A study evaluating predictive and prognostic role of the expression of BCL-2 alternative proteins in CLL patients treated with venetoclax
Latest Information Update: 02 Jun 2021
At a glance
- Drugs Venetoclax (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
Most Recent Events
- 01 May 2021 Results published in the Leukemia and Lymphoma
- 07 Jul 2020 New trial record
- 24 Jun 2020 Results presented at the 111th Annual Meeting of the American Association for Cancer Research - II